Bob Dillman

Company: AIVITA Biomedical

Job title: Chief Medical Officer

Seminars:

AV-GBM-1 Patient-Specific Vaccines in Newly Diagnosed Primary Glioblastoma 4:45 pm

AV-GBM-1 product and manufacturing feasibility update Phase 2 safety and survival data including exploratory subset analyses Phase 3 clinical trial considerations and designRead more

day: Day One